Background. Limited evidence is available on a gene-environmental interaction of angiotensin-converting enzyme (ACE) gene I/D polymorphism and high blood pressure with salt intake among general populations. We hypothesized that persons with the I allele of ACE gene have elevated blood pressure levels in response to a higher sodium intake, and thus the association of ACE I/D polymorphism with blood pressure levels was stronger among persons with a higher sodium intake than those with a lower sodium intake.
INTRODUCTION
Angiotensin-converting enzyme (ACE) I/D polymorphism is a polymorphism of either presence or absence of 287 base-pair DNA fragment in intron 16 of ACE gene. 1 Genetic associations between polymorphism of the ACE I/D and high blood pressure (BP) have been examined extensively, but findings on the association have been inconsistent. Some studies [2] [3] [4] , but not all [5] [6] [7] , reported that the D allele was responsible for elevation of BP while other clinical studies showed that I allele, but not D allele, was associated with hypertension. 8, 9 As for salt-sensitive hypertension, two clinical studies [10] [11] [12] found a significant association with I allele; one study 13 showed an association with D allele; and three studies [14] [15] [16] showed no association. However, no population-based study was conducted for the association between I/D polymorphism and salt-sensitive hypertension, probably due to difficulty in the identification of salt-sensitive hypertension in community-based samples.
The aim of this study is to clarify the effect of sodium intake on association between ACE I/D polymorphism and BP among free-living community population. We hypothesized a priori that persons with the I allele of ACE gene elevated BP levels in response to higher sodium intake, and thus the association between I/D polymorphism and BP was stronger among persons with a higher sodium intake than those with a lower sodium intake. To examine the potential gene-environmental interaction, we conducted a large community-based observational study of 2,823 Japanese men and women.
METHODS

Study Population
Study population we used was similar to that of our previous reports. 17, 18 Briefly, we recruited the subjects from a farming rural community of Kyowa, Ibaraki prefecture, central Japan Well-trained BP observers measured arterial systolic blood pressure (SBP) and fifth-phase diastolic blood pressure (DBP) using standard mercury sphygmomanometers (with 14cm width and 51cm length cuff) on the right arm of quietly seated participants after at least five-minute rest. When the first SBP reading was ≥140 mmHg and/or DBP ≥90mmHg, the measurement was repeated; the average of first and second readings was used in the analyses, and otherwise the first reading was used. We measured several potential confounders: body mass index (BMI), alcohol intake, urinary sodium and potassium excretion estimated by 24-hour urine collection, and past and present sodium intake scores estimated by self-administered questionnaire.
All participants in the survey were asked to complete self-administered questionnaire to estimate both present and past habitual sodium intake. Past sodium intake was defined as the intake before the recognition of hypertension for hypertensives, and approximately 10 years before the survey for normotensives. A sodium intake score was calculated by adding one point for each of 10 types of sodium intake: 1) prefer salty-food, 2) use salty seasoning,
3) eat two or more miso soup servings per day, 4) eat pickles twice or more times per day, 5)
eat salty pickles, 6) put soy sauce on pickles, 7) put soy sauce on meal, 8) eat salt-preserved food one or more times per week, 9) eat salty noodle soup, and 10) do not try to reduce salt intake. This scoring system was previously validated [18] [19] [20] , and again tested in the present study.
Age and sex-adjusted mean 24-hour sodium excretion values across quintiles of the present sodium intake score (n = 1,913) were 168, 183, 193, 201 and 202 mmol/L (p for trend < 0.001). Repeatability of the present and past sodium intake scores was also tested previously 17, 20 by repeating the questionnaire one to two years apart for a sub-sample (n = 287); the Spearman correlation coefficient was 0.73 for the present sodium intake score (p<0.001), and 0.62 for the past sodium intake score (p<0.001). 17 In the present study, 99% of the subjects completed sodium intake questionnaire.
To estimate salt intake more accurately, some participants collected one 24-hour urine sample, as previously reported. 17, 18 Urine samplings with lower than 500 ml or those with incomplete collections based on the records were excluded from the analyses. We included in the analyses a total of 1,920 subjects who completed the 24-hour urine collection between 1982 and 2005.
DNA genotyping
ACE I/D genotypes were determined by allele-specific primer-polymerase chain reaction (PCR) method using Taq DNA polymerase (rTaq ; Toyobo, Osaka, Japan), as described elsewhere. 21, 22 The designed allele-specific sense primers were 
Statistical analyses
Analysis of covariance and chi-square tests were used to compare sex-specific age-adjusted mean values and proportions of risk characteristics according to the ACE I/D genotypes with the Tukey's multiple comparison methods. The chi-square test was used to examine whether the genotype distributions differed from that expected from Hardy-Weinberg equilibrium.
The relationship between genotype and BP levels was examined by the analysis of covariance, adjusted for age, sex, antihypertensive medication use, body mass index, and alcohol intake.
The statistical testing for BP differences between the genotypes DD and ID or II was conducted using the Dunnett's multiple comparison methods, stratified by the medians of urinary sodium excretion, and present and past sodium intake score. For the analysis stratified by urinary sodium excretion, survey years of 24-hour urine collection (1982-1986, 1989-1993, 1994-1997, 1998-2001, 2002-2005) were also adjusted. The interactions between genotype and sex, stratified sodium variables in relation to BP levels were examined using cross-product terms of these variables, i.e., polymorphism (DD, ID, II)  sex (M or F), polymorphism  sodium intake/excretion (below or beyond the median value). The hereditary mode was tested by multiple regression models, assigning DD=0 and ID or II=1 for dominant mode; DD or ID=0 and II=1 for recessive mode; and DD=0, ID=1 and II=2 for additive mode.
All statistical analyses were performed using SAS version 9.1.3 (SAS Institute Inc.). All p value for statistical tests were two-tailed, and p<0.05 was regarded as statistical significance.
RESULTS
The frequency of ACE genotypes was 12.3% for DD genotypes, 45.4% for ID genotype, and 42.3% for II genotype. The genotype distribution was in Hardy-Weinberg equilibrium for men (p=1.00), women (p=0.99) and total samples (p=1.00). Table 1 summarizes sex-specific clinical and laboratory characteristics. Mean age was 59 years for men and 57 years for women. The prevalence of hypertension was 48% for men and 38% for women, and mean 24-hour urine sodium excretion was 205mmol and 179mmol, respectively. Table 2 provides sex-specific age-adjusted characteristics according to the genotype.
For each sex and total samples, mean age did not vary among DD, ID and II groups. Either mean SBP or DBP levels was not different among three groups. Also, the prevalence of antihypertensive medication use and prevalence of hypertension did not differ among three groups. The other factors, i.e. BMI, alcohol intake, urine sodium excretion, past and present sodium intake score did not vary among three groups.
Mean values of BP levels adjusting for sex, age, antihypertensive medication use, BMI, and alcohol consumption among ACE genotypes are shown in Table 3 . There was no significant difference in BP levels between DD, ID and II groups for each sex and total samples. However, among subjects with higher sodium excretion, mean diastolic BP was higher in those with ID genotype (+3.0mmHg, p=0.003) and II genotype (+3.0mmHg, p=0.003) than in those with DD genotype for total subjects, but not among those with lower sodium excretion (p=0.02 for interaction). Among subjects with higher sodium excretion, the hereditary mode was statistically significant for dominant mode (p<0.001) and additive mode (p=0.01), but not for recessive mode (p=0.26).
Among subjects with higher present sodium intake, mean DBP levels was higher in ID and II groups compared with DD group for total subjects (+1.7mmHg, p=0.05 and +1.8mmHg, p=0.04, respectively), but not for those with lower present sodium intake; however the interaction did not reach statistical significance (p=0.17). Among subjects with higher present sodium intake, the p-values for hereditary mode were 0.02 for dominant, 0.37 for recessive, and 0.07 for additive modes. Correspondingly, among subjects with higher past sodium intake, mean DBP levels tended to be higher in ID and II group compared with DD group for total subjects (+1.6 mmHg, p=0.06, and +1.7mmHg, p=0.06, respectively), but not for those with lower present sodium intake albeit insignificant interaction (p=0.24). Among subjects with higher past sodium intake, the hereditary mode were 0.03 for dominant, 0.46 for recessive, and 0.10 for additive modes. These trends among subgroups of each high sodium variables were similarly observed between men and women (sex interaction p=0.19 for higher sodium excretion, p=0.84 and 0.98 for higher present and past sodium intake, respectively), although these trends for each sex did not reach statistical significance probably due to the small number of DD subjects.
These results did not alter materially when restricting subjects without were essentially same as shown in Table 3 .
DISCUSSION
In this large community-based association study, there was no significant difference in BP levels among DD, ID and II groups for either sex or total samples. However, we observed significant associations between I allele and elevated BP levels among persons with higher sodium excretion and higher past or present sodium intake scores, as we hypothesized a priori. Two previous studies revealed a positive association between I allele and salt-sensitivity among hypertensives. A study of 66 Japanese hypertensives showed that the prevalence of I allele was 77% among salt-sensitive hypertensives, whereas that of D allele was 55% among salt-resistant hypertensives. 10 Another study of 48 Spanish hypertensives showed that patients with II genotype had elevated 24-hour BP after higher salt diet period compared with after lower salt diet period (+9.8mmHg for SBP and +5.2 for DBP), whereas patients with DD genotype showed smaller changes (+1.2mmHg for SBP and -0.2mmHg for DBP) 11 , which was confirmed by their subsequent study of larger samples (n=71). 12 Recently, a cross-sectional study of 284 Japanese male workers showed a positive association between salt intake estimated by food frequency questionnaire and the proportion of hypertension among men with ACE I allele (39% for men with the highest tertile (≥10.78 g/day) salt intake vs 19% for those with lowest tertile (≤8.15 g/day)), but not among those without it. 23 Also, the European Project on Genes in Hypertension (EPOGH), a recent large family and population-based collaborative study, showed that the left ventricular mass was higher in II genotype than in ID+DD genotype among Slavic offsprings with higher sodium excretion, but not among those with lower sodium excretion. 24 The present study extended evidence that sodium intake modifies the association of ACE I/D polymorphism with BP in a large free-living population.
We used large free-living community-based samples, which was the strength of the present study. Furthermore, we obtained sodium intake scores for 99% of subjects and 24-hour urine collection samples for 68% of subjects, which allowed us to test gene-environmental interactions of ACE I/D polymorphism with BP levels. As for I/D polymorphism, no previous association study estimated the relationship between salt intake and BP or hypertension in a community-based samples, and the number of subjects on the previous studies of salt-related hypertension was approximately 30-300 23, 25 , which was one-sixth or less of the present study.
The present study has the several limitations. First, we used only single BP measurement in the analyses so that measurement variability may have weakened the genetic associations. However, since the number of the study subjects was large, we attained enough statistical power to detect gene-BP associations. When we used the first reading of BP, or means of BP data measured in 2000 and 2001 surveys, the results did not alter materially.
Second, approximately 20% of subjects used antihypertensive medication which may obscure the genetic effect on BP levels. However, since the prevalence of antihypertensive medication use did not differ among the genotypes, this is unlikely. Third, we did not have the individual information which kind of drugs had been prescribed to the subjects for antihypertensive medication. Some antihypertensive drugs may modify the gene-BP association. However in this community, the majority of hypertensive patients seem to be treated primarily by calcium channel blockade like in other communities of Japan. Furthermore, the exclusion of persons on antihypertensive medication did not materially alter the genetic associations. Fourth, the variation of sodium excretion by one 24-h urine sample may be large and the misclassification between low and high sodium excretion groups is inevitable during a long sampling term. In the present study, however, 66% of persons remained in the same group of higher or lower sodium intake estimated from 24-h urine collection conducted within 5 years.
Therefore, since our study had a large sample size, the impact of misclassification across the stratification is probably small. Fifth, a large time distance between BP measurement and urine collection at most 19 years would make the interpretation for the results difficult.
However, when we restricted the urine data of 2001±5 years (i.e. 1996-2005), the results did not alter materially. Last, BP levels were sometimes lower in groups of higher sodium excretion or intake than in those of the lower ones in each genotype. A plausible reason for this phenomenon is that most of the hypertensive persons attempt to reduce sodium intake when they recognized their blood pressure levels were high, since sodium modification has been the most common strategy for prevention and control of hypertension in Japanese society. 26 The present study showed that differences in mean value of DBP between DD and II groups was 2-3mmHg for persons with higher salt intake, which seemed to be small from a viewpoint of clinical practice. However, meta-analyses of nine prospective observational studies demonstrated that a long-term difference of 5mmHg in mean DBP was associated with 34% less stroke and 21% less coronary heart disease. 27 Therefore, our finding, taken together with the results from the meta-analyses, was consistent with the possibility that salt reduction for persons with ACE I allele may have a substantial impact on prevention of cardiovascular disease.
In conclusion, ACE I allele was associated with higher DBP levels in persons with a higher sodium intake. The present study supports the hypothesis that ACE I allele may play a role of salt-sensitive hypertension. Present sodium intake score 5.7 ± 1.9 4.6 ± 1.9 5.0 ± 1.9
Past sodium questionnaire completed, n 1,031 1,761 2,792
Past sodium intake score 6.8 ± 1.8 5.9 ± 2.0 6.3 ± 2.0 No statistical significance were observed for age-adjusted means or proportions of characteristics according to genotype using Tukey's multiple comparison methods. †Hypertension was defined as systolic blood pressure of ≥ 140 mmHg and/or diastolic blood pressure, of ≥ 90 mmHg and/or use of antihypertensive medication. Blood pressures were adjusted for sex, age, antihypertensive medication use, body mass index and alcohol intake, and for the analysis stratified by urinary sodium excretion, survey years of 24-hour urine collection. Tests for difference from DD genotype were conducted using Dunnett's multiple comparison method. Medians are 195.7 mmol/day for urinary sodium excretion in men and 171.2 mmol/day in women, 5 for present sodium intake score in women and 6 in men, 6 for past sodium intake score in women, and 7 in men.. 
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